Cardinal Health

Courtesy of Cardinal Health
  • Previous Rank
    21
  • Revenues ($M)
    121546
  • Revenue Percent Change
    18.5
  • Profits ($M)
    1427
  • Profits Percent Change
    17.4
  • Assets ($M)
    34122
  • Employees
    37300
  • Market Value — as of March 31, 2017 ($M)
    25725

Cardinal Health, a drug wholesaler that also makes gloves and surgical apparel, has been shoring up its future earnings through a series of strategic acquisitions, development of its alternate care business, and promotion of its specialty drug assets. In late 2015 the company acquired Cordis, naviHealth, and Harvard Drug; it spent much of 2016 integrating them, with a 19% increase in annual revenue to show for it. The company's pharmaceutical segment endured ongoing profit pressures for generics and the loss of a major customer but lessened the blows with new drug launches and sales growth; its medical segment grew because of acquisitions. The partnerships and purchases are a way for Cardinal Health to snag a greater share of the medical products sold to hospitals, physicians, and ambulatory centers. The company was founded in 1979 and is headquartered in Dublin, Ohio.

Company Info

CEOGeorge S. Barrett
CEO TitleChairman & Chief Executive Officer
SectorWholesalers
IndustryWholesalers: Health Care
HQ LocationDublin, OH
Websitewww.cardinalhealth.com
Years on Fortune 500 List23
Employees37,300

Key Financials (Last Fiscal Year)

Revenues ($M)$121,546
Profits ($M)$1,427
Assets ($M)$34,122
Total Stockholder Equity ($M)$6,554
Market Value — as of March 31, 2017 ($M)$25,725

Profit Ratios

Profit as % of Revenues1.2%
Profits as % of Assets4.2%
Profits as % of Stockholder Equity21.8%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)4
EPS % Change (from 2015)19.3%
EPS % Change (5 year annual rate)9.7%
EPS % Change (10 year annual rate)6.4%

Total Return

Total Return to Investors (2016)-17.7%
Total Return to Investors (5 year, annualized)14.5%
Total Return to Investors (10 year, annualized)6.4%